Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reperio Health is a private digital health company focused on preventive care delivery through at-home and onsite biometric screening combined with virtual clinical follow-up. Its core offering, ReperioKit, uses FDA-cleared, Bluetooth-connected devices and a mobile app to deliver immediate results for measures such as blood pressure, glucose, and lipid panels, while ReperioCare connects users to clinicians for on-demand review and next steps. The company primarily sells to employers, health plans, providers, and individuals seeking higher engagement in preventive screening programs. Reperio positions itself as a healthcare access and engagement platform rather than a therapeutics developer, emphasizing convenience, instant results, and care navigation. It has expanded nationwide kit availability in the United States and has built partnerships to link screening with longitudinal primary care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reperio Health.